Dr. Sunil Ahuja oversees an inter- and multi-disciplinary research program at the university and the Center for Personalized Medicine at the Veterans Administration hospital that links state-of-the-art genomic, immunologic and molecular technologies with epidemiology, clinical, and animal research to identify the determinants of human diseases such as HIV, allergy, and autoimmunity.
Okulicz JF, Le T, Agan BK, Camargo J, Landrum
ML, Wright EJ, Dolan MJ, Ganesan A, Ferguson TM, Smith DM, Richman DD,
Little SJ, Clark RA, He W, Ahuja SK. Influence of the Timing of Anti-retroviral Therapy on Normalization of Immune Status in HIV-1 Infected Individuals. JAMA Intern Med. 2015, Jan, 175(1):88-99.
Jimenez F, Martinez H, Harper N, Manoharan M, Carrillo A, Ingale P, Liu Y-G,
Ahuja SS, Clark RA, Rather CG, Ramirez DA, Andrews CP, Jacobs
RL, Ahuja SK. Cockroach Sensitization Mitigates Allergic
Rhinoconjunctivitis Symptom Severity in Individuals Allergic to House Dust
Mites and Pollen. J Allergy Clin. Immunol. 2015.
Jacobs RL, Harper N, He W, Andrews CP, Rather CG, Ramirez DA, Ahuja SK. Effect of confounding cofactors on responses to pollens during natural season versus pollen challenge chamber exposure. J Allergy Clin Immunol. 2013 Dec 9.
Le T, Wright EJ, Smith DM, He W, Catano G, Okulicz JF, Young JA, Clark RA, Richman DD, Little SJ, Ahuja SK. Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy. N Engl J Med. 2013 Jan 17;368(3):218-30.
Jacobs RL, Harper N, He W, Andrews CP, Rather CG, Ramirez DA, Ahuja SK. Responses to ragweed pollen in a pollen challenge chamber versus seasonal exposure identify allergic rhinoconjunctivitis endotypes. J Allergy Clin Immunol. 2012 Jul;130(1):122-7.e8.
He W, Neil S, Kulkarni H, Wright E, Agan BK, Marconi VC, Dolan MJ, Weiss RA, Ahuja SK. Duffy
antigen receptor for chemokines mediates trans-infection of HIV-1 from
red blood cells to target cells and affects HIV-AIDS susceptibility. Cell Host Microbe. 2008 Jul 17;4(1):52-62.
Burt TD, Agan BK, Marconi VC, He W, Kulkarni H, Mold JE, Cavrois M, Huang Y, Mahley RW, Dolan MJ, McCune JM, Ahuja SK. Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progression. Proc Natl Acad Sci U S A. 2008 Jun 24;105(25):8718-23.
Ahuja SK, Kulkarni H, Catano G, Agan BK, Camargo JF, He W, O'Connell RJ,
Marconi VC, Delmar J, Eron J, Clark RA, Frost S, Martin J, Ahuja SS,
Deeks SG, Little S, Richman D, Hecht FM, Dolan MJ. CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individuals. Nat Med. 2008 Apr;14(4):413-20.
Dolan MJ, Kulkarni H, Camargo JF, He W, Smith A, Anaya JM, Miura T,
Hecht FM, Mamtani M, Pereyra F, Marconi V, Mangano A, Sen L, Bologna R,
Clark RA, Anderson SA, Delmar J, O'Connell RJ, Lloyd A, Martin J, Ahuja
SS, Agan BK, Walker BD, Deeks SG, Ahuja SK. CCL3L1 and CCR5 influence cell-mediated immunity and affect HIV-AIDS pathogenesis via viral entry-independent mechanisms. Nat Immunol. 2007 Dec;8(12):1324-36.
Gonzalez E, Kulkarni H, Bolivar H, Mangano A, Sanchez R, Catano G, Nibbs
RJ, Freedman BI, Quinones MP, Bamshad MJ, Murthy KK, Rovin BH, Bradley
W, Clark RA, Anderson SA, O'connell RJ, Agan BK, Ahuja SS, Bologna R,
Sen L, Dolan MJ, Ahuja SK. The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science. 2005 Mar 4;307(5714):1434-40.